Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Bone Marrow Transplantation|April 11, 2020
CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II studyPooja Khandelwal, Tsuyoshi Fukuda, Ashley Teusink-Cross, et al.
Transplantation and Cellular Therapy|February 14, 2026
Long-term follow-up after mixed donor myeloid chimerism at 1 year post transplantation for sickle cell diseaseGregory M T Guilcher, Stuti Dalal, Tara Suresh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2016
A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell TransplantationPooja Khandelwal, Chie Emoto, Tsuyoshi Fukuda, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2015
Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab RegimenRebecca A Marsh, Marepalli B Rao, Aharon Gefen, et al.
Transplantation and Cellular Therapy|November 2, 2022
Reduced-Intensity Conditioning Mitigates Risk for Primary Ovarian Insufficiency but Does Not Decrease Risk for Infertility in Pediatric and Young Adult Survivors of Hematopoietic Stem Cell TransplantationJonathan D Bender, Helen Oquendo-Del Toro, Janie Benoit, et al.
Nature Medicine|May 26, 2025
Lentiviral gene therapy with reduced-intensity conditioning for sickle cell disease: a phase 1/2 trialMichael Grimley, Stella M Davies, Archana Shrestha, et al.
Blood Advances|February 11, 2021
A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplantChristopher E Dandoy, Seth Rotz, Priscila Badia Alonso, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 29, 2017
Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research ReportPooja Khandelwal, Heather R Millard, Elizabeth Thiel, et al.
Blood Advances|May 5, 2019
GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemiaRohtesh S Mehta, Shernan G Holtan, Tao Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 16, 2019
Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell TransplantationAyman Saad, Lawrence Lamb, Tao Wang, et al.
Pageof 6